Retraction
Apatinib Functioned as Tumor Suppressor of Synovial Sarcoma through Regulating miR-34a-5p/HOXA13 Axis
Paper Information
Record ID:
60414
Author(s):
Publication Date:
October 12, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Specific Fields:
Biochemistry Biology - Molecular Genetics Medicine - Oncology Medicine - Pharmacology
Biochemistry Biology - Molecular Genetics Medicine - Oncology Medicine - Pharmacology
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
p53/MicroRNA-34 axis in cancer and beyond
Wei Pan, Binshu Chai, Li Langping et al. (5 authors)
Heliyon
Open Access
Published: Apr 2023
26 citations
26 citations
242 days before retraction
ETC-159, an Upstream Wnt inhibitor, Induces Tumour Necrosis via Modulation of Angiogenesis in Osteosarcoma
Kenon Chua, Arthur Yi Loong Sim, Eric Yeo et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2023
9 citations
9 citations
273 days before retraction
Retracted: Apatinib Functioned as Tumor Suppressor of Synovial Sarcoma through Regulating miR‐34a‐5p/HOXA13 Axis
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025